Bio Green Med Solution, Inc.(BGMS)

Medical - Pharmaceuticals · Kuala Lumpur, LF

$0.87-0.01 (-1.32%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T12:45:39.213Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:45:39.213Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 4,793,095
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 3,790,000
TTM operating EBITDA · period ending 2026-06-30: -2,730,500

FMP input reference: c636d25f821ca328dde5756eba65a9b4f657646c0770229dc3782e5e279f5fe4

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BGMS EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

BGMS Competitors' EV/EBITDA Ratio

BGMS

Bio Green Med Solution, Inc.

Current

Market Cap

$4.79M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CALC

CalciMedica, Inc.

vs BGMS

Market Cap

$4.85M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMGL

Basel Medical Group Ltd Ordinary Shares

vs BGMS

Market Cap

$4.96M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs BGMS

Market Cap

$4.99M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRMA

Dermata Therapeutics, Inc.

vs BGMS

Market Cap

$4.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLGN

CollPlant Biotechnologies Ltd.

vs BGMS

Market Cap

$4.42M

EV/EBITDA Ratio

N/A

TTM Avg

72.60x

3Y Avg

72.60x

5Y Avg

72.60x

ERNA

Ernexa Therapeutics Inc.

vs BGMS

Market Cap

$4.41M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIDX

20/20 Biolabs Inc.

vs BGMS

Market Cap

$4.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALZN

Alzamend Neuro Inc

vs BGMS

Market Cap

$5.36M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRI

GRI Bio, Inc.

vs BGMS

Market Cap

$4.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Bio Green Med Solution, Inc. (BGMS)	$4.79M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.85M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$4.96M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$4.99M	N/A	N/A	N/A	N/A
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.46M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.42M	N/A	72.60x	72.60x	72.60x
Ernexa Therapeutics Inc. (ERNA)vs ›	$4.41M	N/A	N/A	N/A	N/A
20/20 Biolabs Inc. (AIDX)vs ›	$4.32M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.36M	N/A	N/A	N/A	N/A
GRI Bio, Inc. (GRI)vs ›	$4.18M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics